Impact Biomedical (IBO) Payables (2022 - 2026)
Impact Biomedical (IBO) posted Payables of $374000.0 for Q1 2026, up 7.78% on a QoQ basis from $347000.0 in Q4 2025, and down 96.17% year-over-year from $9.8 million in Q1 2025.
Impact Biomedical (IBO) Payables (2022 - 2026) Analysis & Trends
Impact Biomedical's Payables history runs 5 years deep, the most recent figure standing at $374000.0 for Q1 2026.
- Quarterly Payables fell 96.17% year-over-year to $374000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $374000.0 (down 96.17% YoY) and the FY2025 annual result came in at $347000.0, down 96.38% from the prior year.
- Payables was $374000.0 for Q1 2026 at Impact Biomedical, up from $347000.0 in the prior quarter.
- Across five years, Payables topped out at $23.5 million in Q3 2025 and bottomed at $347000.0 in Q4 2025.
- A 5-year average of $11.0 million and a median of $12.1 million in 2023 frame the typical range for Payables.
- Peak annual rise in Payables reached 2164.19% in 2025, while the deepest fall reached 96.38% in 2025.
- Impact Biomedical's Payables stood at $10.5 million in 2022, then grew by 22.56% to $12.9 million in 2023, then dropped by 25.69% to $9.6 million in 2024, then tumbled by 96.38% to $347000.0 in 2025, then climbed by 7.78% to $374000.0 in 2026.
- Business Quant data shows IBO's Payables at $374000.0 in Q1 2026, $347000.0 in Q4 2025, and $23.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 374,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 23.46 Mn |
| Jun 30, 2025 | 22.91 Mn |
| Mar 31, 2025 | 9.76 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 14.44 Mn |
| Mar 31, 2024 | 13.81 Mn |
| Dec 31, 2023 | 12.91 Mn |
| Sep 30, 2023 | 12.26 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Dec 31, 2022 | 10.53 Mn |